TICOVAC Junior is a pediatric vaccine designed to provide protection against tick-borne encephalitis (TBE), a viral infectious disease that affects the central nervous system. This vaccine is specifically formulated for children, offering a tailored dosage and administration schedule to ensure effective immunization against the virus commonly transmitted through tick bites. TICOVAC Junior works by stimulating the body's immune response to the TBE virus, preparing the immune system to recognize and fight the virus if exposed in the future. It is part of a broader public health strategy to combat TBE in regions where the virus is endemic, providing a critical tool in preventing the potentially severe consequences of the disease in the pediatric population.